With the deaths of young DMD boys and the long term side effects in question.. I can’t see the FDA passing the gene therapy drug . Not only that the high cost and the drug failed to show efficacy Imo the FDA will not give approval for the entire DMD population
PER is only days away from full enrolment .. Then the countdown begins… We already have more than 10 boys who are dosing beyond the 6 month period All good. Also the Tox study is completed or near enough the fact that they haven’t stoped the trial tells me that the 9 month study is successful.
..
PER Price at posting:
7.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)